Monday, October 2, 2023
Monday, October 2, 2023

Contact: 561.316.3330

LeAnn Affholter and Carla Pagotto Join the Cardiac Insight Leadership Team: Solid and Seasoned Professionals “Jump Right In”

December 21, 2020

LeAnn Affholter and Carla Pagotto have joined the Cardiac Insight Leadership team.

LeeAnn Affholter will serve as Vice President of People and Carla Pagotto as the Vice President of Marketing.

“The value LeAnn Affholter and Carla Pagotto add to the Cardiac Insight leadership team is immeasurable, particularly during a year where we have experienced unprecedented challenges and opportunities. The two have jumped right in and taken both in stride,” said Bob Odell, President, and COO of Cardiac Insight.”

Odell adds, “Carla’s solid experience in the medical device and life sciences sectors and her global perspective brings fresh eyes to our marketing department, timed perfectly with a record growth year for Cardiac Insight, which we anticipate will accelerate in 2021. LeAnn is a seasoned human resources professional who has worked in every facet of the HR space. She will be a tremendous asset to our growing business operations particularly from a talent acquisition and development standpoint.”

LeAnn brings a breadth of experience in all areas of human resources, including strategic planning, change management, creation and development of high-performing HR departments and teams, and improvement of overall company effectiveness. She has worked in a variety of industries, although most of her career has been in biotech. Most recently, LeAnn comes from PSF Mechanical, Inc. where she was VP of Human Resources, and she previously worked with Acucela Inc., Dendreon, and Pathway Medical Technologies. LeAnn earned her B.A. in Communications from the University of Arizona.

Carla brings extensive global and regional experience in strategic planning, commercial and marketing excellence, portfolio management, and product development, both in the medical device and life sciences industries. Most recently, she worked as a consultant based in Switzerland advising early-stage companies on marketing, product launches, and go-to-market strategic planning.

Carla has held senior leadership positions at several established companies, including at BD and Medtronic, Inc. in both the United States and Europe. Carla earned her M.B.A. from Rice University Jones School of Business and her B.A. from the University of Michigan.

LeAnn and Carla join Cardiac Insight alongside over a dozen new sales executives, as Cardiac Insight continues to drive continued growth and accelerate access and adoption of its technology.

Further leveraging leadership team capabilities, Ann Demaree, RN, formerly Cardiac Insight’s Vice President of Marketing and Business Development, was promoted to Senior Vice President of Business Development.

With over fifteen years of prior medical device industry experience in both buy-side and sell-side corporate M&A, strategic partnering, and licensing, Ann is responsible for investor relations, growing strategic business alliances and clinical research opportunities, and expanding Cardiac Insight’s reach outside of the United States.

Employee growth comes parallel to Cardiac Insight’s Q3 record market growth. “We’re seeing tremendous market opportunity in our space, especially as cardiology steps into the spotlight amid the pandemic and physicians turn their attention to risks associated with significantly undiagnosed cardiac arrhythmias,” continued Odell. “We remain opportunistic and optimistic about the road ahead.”

Cardiac Insight, a privately held ECG technology innovator, provides the only all-inclusive seven-day ambulatory ECG system that comes complete with in-office rapid automated analysis and reporting to detect arrhythmias, including atrial fibrillation, eliminating the need for outsourced ECG services. The unobtrusive, single-use Cardea SOLO wearable sensors and the immediate availability of results for physician review are key patient– and clinician-friendly benefits driving the switch from traditional Holter ECGs and service-based wearables to the new Cardea SOLO System and shortening the overall time to diagnosis (seven days or less).

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Broken String Biosciences Strengthens Senior Leadership Team

Bringing significant expertise in their respective fields, Vincent Smith, PhD and Jessica Rich appointments are a key part of Broken String’s strategy to deliver on its Series A goals, which include the continued development of its INDUCE-seq™ DNA break-mapping platform and acceleration of its commercial expansion across global markets.

New Chief Sales Officer at Encare with Focus on Continued Global Expansion

The HealthTech company Encare has recruited Lotta Sellén as the new Chief Sales Officer (CSO). Lotta Sellén has solid experience in the pharmaceutical, healthcare and HealthTech industries.

CorWave Appoints Magalie Durrèche as Chief Financial Officer

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

Veracyte Names Dr Phillip G Febbo Chief Scientific Officer and Chief Medical Officer

“Phil G Febbo is an exceptional leader with a strong track record of driving successful commercialization of molecular tests through evidence development, guideline inclusion and key opinion leader support,” said Mr. Stapley. “His experience and expertise will be critical to further enhancing our ability to serve our customers and, ultimately, to transforming cancer care for patients all over the world.”

GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

Dr Aaron Tendler is a board-certified psychiatrist based in Palm Beach, Florida, bringing over 20 years of experience as an industry leader researching novel treatments for mental health disorders.

By using this website you agree to accept Medical Device News Magazine Privacy Policy